The present invention provides binding molecules that specifically bind to SARS-CoV, nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules are capable of specifically binding to SARS-CoV and can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from SARS-CoV.

 
Web www.patentalert.com

< Apparatus and method for analyzing bacteria

> Site-directed modification of FVIII

> Porous materials embedded with nanospecies, methods of fabrication thereof, and methods of use thereof

~ 00597